Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset

To assess the gap between visual acuity (VA) outcomes with anti-vascular endothelial growth factor (anti-VEGF) therapies in clinical trials and real-world practice, and explore the reasons for this gap. The literature was searched from January 1, 2013, to June 30, 2018, for studies reporting VA gain...

Full description

Bibliographic Details

Published in:	Ophthalmologica (Basel) Vol. 243; no. 1; p. 1
Main Authors:	Monés, Jordi, Singh, Rishi P, Bandello, Francesco, Souied, Eric, Liu, Xin, Gale, Richard
Format:	Journal Article
Language:	English
Published:	Switzerland 2020
Subjects:	Anti-VEGF Undertreatment Neovascular age-related macular degeneration Treatment burden
ISSN:	1423-0267, 1423-0267
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!